Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation

American Journal of Pathology

Volumn 159, Issue 4, 2001, Pages 1193-1197

  Weisberg, Shira ^a   Ashkenazi, Ely ^b   Israel, Zvi ^b   Attia, Moshe ^b   Shoshan, Yigal ^b   Umansky, Felix ^b   Brodie, Chaya ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0034785516     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62504-7     Document Type: Article

References (32)

1. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas
2. Apoptotic activity and bcl-2 immuno-reactivity in meningiomas: Association with grade and outcome
3. Apoptosis is associated with atypical or malignant change in meningiomas: An in situ labelling and immunohistochemical study
4. Expression of apoptotic and proliferation markers in meningiomas
5. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas
6. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: Sequence identity with the Fas antigen
7. Structure and function of Fas/Fas ligand
8. The role of APO-1-mediated apoptosis in the immune system
9. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
10. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
11. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death
12. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
13. Staurosporine induces astrocytic phenotypes and differential expression of specific PKC isoforms
14. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal
15. Death receptors in cutaneous biology and disease
16. The cardiac Fas (APO-1/CD95) receptor/Fas ligand system: Relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes
17. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
18. A comparative study of Fas and Fas-ligand expression during melanoma progression
19. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer
20. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma
21. Expression of Fas/APO-1 during the progression of astrocytomas
22. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas
23. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
24. Purification and characterization of the Fas-ligand that induces apoptosis
25. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
26. FLIP is constitutively hyperexpressed in Fas-resistant U266 myeloma cells, but is not induced by IL-6 in Fas-sensitive RPM18226 cells
27. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells
28. Proliferation and DNA fragmentation in meningioma subtypes
29. Atypical and malignant meningiomas: Importance of micronecrosis as a prognostic indicator
30. Current treatment of meningiomas